Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum

The Journal of Clinical Investigation
M KornmannM Korc

Abstract

Cyclin D1 belongs to a family of protein kinases that have been implicated in cell cycle regulation. Recent studies have demonstrated that elevated cyclin D1 levels correlate with decreased survival in human pancreatic cancer. In this study we expressed in a stable manner a cyclin D1 antisense cDNA construct in PANC-1 human pancreatic cancer cells. Expression of the antisense construct caused a decrease in cyclin D1 mRNA and protein levels and in cyclin D1-associated kinase activity. Antisense expressing clones displayed significantly increased doubling times, decreased anchorage-dependent and -independent basal growth, and complete loss of tumorigenicity in nude mice. EGF, FGF-2, and IGF-I enhanced mitogen-activated protein kinase activity in antisense expressing clones, but failed to stimulate their proliferation. In contrast, all three growth factors were mitogenic in parental cells. Furthermore, the inhibitory effect of cisplatinum on cell proliferation was enhanced markedly in the antisense expressing clones. These findings indicate that cyclin D1 overexpression contributes to abnormal growth and tumorigenicity in human pancreatic cancer and to the resistance of pancreatic cancer to chemotherapeutic agents.

References

Jul 29, 1977·Science·A W Hamburger, S E Salmon
May 1, 1990·Drugs·D J Black, R B Livingston
Nov 3, 1989·Science·A B Pardee
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M KorcJ Trent
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J J SmithM Korc
Dec 1, 1994·Seminars in Cell Biology·J Pines
Dec 1, 1994·Current Opinion in Cell Biology·G F Draetta
Dec 1, 1994·Current Opinion in Cell Biology·E W Lam, N B La Thangue
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·T MoriaiM Korc
Nov 18, 1994·Cell·C J Sherr
Jul 15, 1994·International Journal of Cancer. Journal International Du Cancer·G BerrozpeM Perucho
May 1, 1993·Genes & Development·V BaldinG Draetta
May 25, 1993·Biochimica Et Biophysica Acta·T Motokura, A Arnold
Sep 18, 1996·Journal of the National Cancer Institute·D HochhauserJ R Bertino
Dec 11, 1996·International Journal of Cancer. Journal International Du Cancer·M WagnerM Korc
Feb 1, 1997·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·K H LinkH G Beger
Sep 1, 1997·Neurochemistry International·B WeissS P Zhang

❮ Previous
Next ❯

Citations

Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·J LuoM Korc
Dec 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·Manuel Rieber, Mary Strasberg Rieber
Mar 21, 2003·Biochemical and Biophysical Research Communications·Osvaldo ReyEnrique Rozengurt
Sep 12, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·M GuggerD C Betticher
Mar 2, 2002·International Journal of Radiation Oncology, Biology, Physics·Luka MilasK Kian Ang
Mar 11, 1999·Current Opinion in Genetics & Development·M D Garrett, A Fattaey
May 22, 2003·Journal of the National Cancer Institute·Yu-Long HuRobert B Jaffe
Mar 14, 2000·Annals of Surgery·M KornmannM Korc
Jul 9, 2002·Molecular and Cellular Biology·Akihide RyoKun Ping Lu
Aug 25, 2012·Oxidative Medicine and Cellular Longevity·Carlota OleagaMaria Izquierdo-Pulido
Dec 8, 2007·The Journal of Clinical Investigation·Takuma AikawaMurray Korc
Jul 19, 2013·World Journal of Gastroenterology : WJG·Lin-Hai YanYu-Bo Xie
Jan 19, 2002·Biochemical and Biophysical Research Communications·Jianghua ShaoToshiyoshi Fujiwara
Oct 28, 2009·Expert Opinion on Biological Therapy·Jin XuDeliang Fu
Mar 14, 2002·Expert Opinion on Biological Therapy·John Nemunaitis, John O'Brien
Jan 9, 2004·Cell Proliferation·M A ParkerR D Beauchamp
Mar 16, 2007·Cancer Science·Etsu TashiroMasaya Imoto
Dec 15, 2012·Cancer Science·Ryota TakahashiKazuhiko Koike
Sep 17, 2013·Journal of Cellular Biochemistry·Lin-Hai YanQiang Xiao
Feb 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H DoucasD P Berry
Jun 29, 2013·Journal of Experimental & Clinical Cancer Research : CR·Yong GuoFenghua Chen
Jul 19, 2006·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·H DoucasD P Berry
Jul 26, 2006·Cell Division·Karen E Knudsen
Feb 19, 2015·Archives of Toxicology·Feng LiGautam Sethi
Aug 3, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Li YuHua Liu
Jun 18, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew Arnold, Alexandros Papanikolaou
Mar 30, 2017·International Journal of Molecular Sciences·Benno TraubMarko Kornmann
Feb 14, 2007·Oncogene·C Berthet, P Kaldis
Oct 7, 2003·Oncogene·Adrian M Senderowicz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.